HORSHAM, Pa.--(BUSINESS WIRE)--Oct. 31, 2014--
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference
call to discuss the Company’s third quarter 2014 financial results on
Thursday, November 6, 2014 at 8:30 a.m. Eastern Time.
A press release to announce those results will be issued on November 6th,
prior to the opening of the U.S. stock market.
To participate in the conference call, dial toll free 888-428-9473 or
International/toll 719-457-1512 (and confirmation code # 5919055)
approximately five to 10 minutes prior to the scheduled start time. For
the convenience of our Israeli participants, a local/toll free number
(1-80-924-5906) has been set up (the confirmation code remains the same
# 5919055). If you are unable to participate, a digital replay of the
call will be available from Thursday, November 6, from 11:30 a.m. ET to
Thursday, November 20, 2014 at 11:30 a.m. ET, by dialing toll free
888-203-1112 or International/toll 719-457-0820 (Israeli participants
may dial 1-80-924-6038) and using confirmation code # 5919055.
The live broadcast of PhotoMedex, Inc.’s quarterly conference call will
be available online by going to www.photomedex.com
and clicking on the link to Investor Relations, and at www.streetevents.com.
The online replay will be available shortly after the call at those
sites.
About PhotoMedex
PhotoMedex is a global skin health company providing integrated disease
management and aesthetic solutions to dermatologists, professional
aestheticians and consumers. The company provides proprietary products
and services that address skin diseases and conditions including
psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain
types of skin cancer) and photo damage. Its experience in the physician
market provides the platform to expand its skin health solutions to spa
markets, as well as traditional retail, online and infomercial outlets
for home-use products. As a result of its December 2011 merger with
Radiancy, Inc., PhotoMedex has added a range of home-use devices under
the no!no!™ brand, for various indications including hair removal, acne
treatment and skin rejuvenation. The company also offers a professional
product line for acne clearance, skin tightening, psoriasis care and
hair removal sold to physician clinics and spas. PhotoMedex further
expanded its base through the acquisition of LCA-Vision a leading
provider of laser vision correction services under the LasikPlus®
brand, operates 60 LasikPlus® vision centers in the
United States: 51 full-service LasikPlus® fixed-site
laser vision correction centers and nine pre- and post-operative LasikPlus®
satellite centers. LCA-Vision has performed more than 1.3 million
procedures since FDA approval of photorefractive keratectomy (PRK) in
late 1995.
Source: PhotoMedex, Inc.
LHA, Inc.
Investors
Kim Sutton Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce
Voss, 310-691-7100
Bvoss@lhai.com
or
PhotoMedex,
Inc.
Dennis McGrath, 215-619-3287
CFO
info@photomedex.com
